This study is testing how well a new continuous glucose monitor (CGM) called CareSens Air 3 measures blood sugar levels in adults with type 1 diabetes. Participants will wear the new device and a comparison device for 16 days while checking their blood sugar with fingersticks. Th…
Phase: NA • Sponsor: i-SENS, Inc. • Aim: Diagnosis
Last updated Mar 18, 2026 14:40 UTC